-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on CVS Health, Raises Price Target to $98

Benzinga·12/10/2025 17:51:18
Listen to the news
Truist Securities analyst David Macdonald maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $95 to $98.